 |
(NaturalNews) Google DeepMind CEO Demis Hassabis announced that AI-designed drugs from Isomorphic Labs, a Google spin-out, are expected to enter clinical… |
AI-designed drugs set to enter clinical trials: A new era of health or a Trojan horse for corporate control?
ByPimpHesus
Mar 7, 2025